{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:37:40Z","timestamp":1768484260735,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41433-025-03751-z","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:14:00Z","timestamp":1742051640000},"page":"1772-1780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of uveitis manifestations in patients with active systemic tuberculosis and those with positive interferon-gamma release assay without active disease"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9350-5133","authenticated-orcid":false,"given":"Ikhwanuliman","family":"Putera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniki","family":"Rothova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-5341","authenticated-orcid":false,"given":"Rina","family":"La Distia Nora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"3751_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.76","volume":"2","author":"M Pai","year":"2016","unstructured":"Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, et al. Tuberculosis. Nat Rev Dis Prim. 2016;2:16076.","journal-title":"Nat Rev Dis Prim"},{"key":"3751_CR2","unstructured":"WHO. Global tuberculosis report 2023. Geneve 2023."},{"key":"3751_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1869-5760-3-1","volume":"3","author":"LP Lara","year":"2013","unstructured":"Lara LP, Ocampo V Jr. Prevalence of presumed ocular tuberculosis among pulmonary tuberculosis patients in a tertiary hospital in the Philippines. J Ophthalmic Inflamm Infect. 2013;3:1.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3751_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s10792-021-01718-z","volume":"41","author":"H Ohara","year":"2021","unstructured":"Ohara H, Harada Y, Hiyama T, Yamane K, Higaki M, Kobayashi T, et al. Incidence of ocular inflammation among patients with active tuberculosis or nontuberculous mycobacterial infections in a tertiary hospital in Japan. Int Ophthalmol. 2021;41:1427\u201336.","journal-title":"Int Ophthalmol"},{"key":"3751_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00130924","volume":"19","author":"J Biswas","year":"1995","unstructured":"Biswas J, Badrinath SS. Ocular morbidity in patients with active systemic tuberculosis. Int Ophthalmol. 1995;19:293\u20138.","journal-title":"Int Ophthalmol"},{"key":"3751_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/0002-9394(67)92860-7","volume":"64","author":"HC Donahue","year":"1967","unstructured":"Donahue HC. Ophthalmologic experience in a tuberculosis sanatorium. Am J Ophthalmol. 1967;64:742\u20138.","journal-title":"Am J Ophthalmol"},{"key":"3751_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2023.101189","volume":"95","author":"I Putera","year":"2023","unstructured":"Putera I, Schrijver B, Ten Berge J, Gupta V, La Distia Nora R, Agrawal R, et al. The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies. Prog Retin Eye Res. 2023;95:101189.","journal-title":"Prog Retin Eye Res"},{"key":"3751_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/09273948.2014.967358","volume":"23","author":"A Gupta","year":"2015","unstructured":"Gupta A, Sharma A, Bansal R, Sharma K. Classification of intraocular tuberculosis. Ocul Immunol Inflamm. 2015;23:7\u201313.","journal-title":"Ocul Immunol Inflamm"},{"key":"3751_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ajo.2009.11.020","volume":"149","author":"A Gupta","year":"2010","unstructured":"Gupta A, Bansal R, Gupta V, Sharma A, Bambery P. Ocular signs predictive of tubercular uveitis. Am J Ophthalmol. 2010;149:562\u201370.","journal-title":"Am J Ophthalmol"},{"key":"3751_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00006982-200110000-00004","volume":"21","author":"A Gupta","year":"2001","unstructured":"Gupta A, Gupta V, Arora S, Dogra MR, Bambery P. PCR-positive tubercular retinal vasculitis: clinical characteristics and management. Retina. 2001;21:435\u201344.","journal-title":"Retina"},{"key":"3751_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.survophthal.2022.10.001","volume":"68","author":"BK Betzler","year":"2023","unstructured":"Betzler BK, Putera I, Testi I, La Distia Nora R, Kempen J, Kon OM, et al. Anti-tubercular therapy in the treatment of tubercular uveitis: A systematic review and meta-analysis. Surv Ophthalmol. 2023;68:241\u201356.","journal-title":"Surv Ophthalmol"},{"key":"3751_CR12","doi-asserted-by":"publisher","first-page":"1702352","DOI":"10.1183\/13993003.02352-2017","volume":"51","author":"KJ Snow","year":"2018","unstructured":"Snow KJ, Sismanidis C, Denholm J, Sawyer Susan M, Graham SM. The incidence of tuberculosis among adolescents and young adults: a global estimate. Eur Respir J. 2018;51:1702352.","journal-title":"Eur Respir J"},{"key":"3751_CR13","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.it.2022.06.004","volume":"43","author":"M Gupta","year":"2022","unstructured":"Gupta M, Srikrishna G, Klein SL, Bishai WR. Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis. Trends Immunol. 2022;43:640\u201356.","journal-title":"Trends Immunol"},{"key":"3751_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/eye.2017.231","volume":"32","author":"R La Distia Nora","year":"2018","unstructured":"La Distia Nora R, Sitompul R, Bakker M, Susiyanti M, Edwar L, Sjamsoe S, et al. Tuberculosis and other causes of uveitis in Indonesia. Eye. 2018;32:546\u201354.","journal-title":"Eye"},{"key":"3751_CR15","unstructured":"Indonesian Society of Respirology. Diagnosis and Treatment Guidelines of Tuberculosis (TB) in Indonesia (TB consensus). Jakarta: Indonesian Society of Respirology; 2011."},{"key":"3751_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14238\/pi41.4.2001.185-90","volume":"41","author":"HMD Nataprawira","year":"2001","unstructured":"Nataprawira HMD, Kartasasmita CB, Rosmayudi O, Agustini H. Diagnosis of pediatric tuberculosis using the Indonesian national concencus for pediatric tuberculosis. Paediatr Indonesiana. 2001;41:185\u201390.","journal-title":"Paediatr Indonesiana"},{"key":"3751_CR17","first-page":"188","volume":"17","author":"RP Takhar","year":"2018","unstructured":"Takhar RP, Mirdha K, Purohit G, Maan L, Bainara MK. Impact of HIV Co-Infection on Clinical Presentation in Patients with TB and Correlation of the Findings with Level of Immune Suppression. Tanaffos. 2018;17:188\u201397.","journal-title":"Tanaffos"},{"key":"3751_CR18","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1086\/651495","volume":"50","author":"TR Sterling","year":"2010","unstructured":"Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: clinical manifestations and treatment. Clin Infect Dis. 2010;50:S223\u201330.","journal-title":"Clin Infect Dis"},{"key":"3751_CR19","unstructured":"World Health Organization. Blindness and vision impairment. 13 October 2022. Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/blindness-and-visual-impairment. Accessed 09 June 2023."},{"key":"3751_CR20","doi-asserted-by":"crossref","unstructured":"Standardization of Uveitis Nomenclature Working Group. Classification Criteria for Tubercular Uveitis. Am J Ophthalmol. 2021;228:142\u201351","DOI":"10.1016\/j.ajo.2021.03.040"},{"key":"3751_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jadohealth.2022.10.036","volume":"72","author":"SS Chiang","year":"2023","unstructured":"Chiang SS, Waterous PM, Atieno VF, Bernays S, Bondarenko Y, Cruz AT, et al. Caring for Adolescents and Young Adults With Tuberculosis or at Risk of Tuberculosis: Consensus Statement From an International Expert Panel. J Adolesc Health. 2023;72:323\u201331.","journal-title":"J Adolesc Health"},{"key":"3751_CR22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/jamaophthalmol.2013.71","volume":"131","author":"SS Patel","year":"2013","unstructured":"Patel SS, Saraiya NV, Tessler HH, Goldstein DA. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol. 2013;131:752\u20138.","journal-title":"JAMA Ophthalmol"},{"key":"3751_CR23","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","volume":"135","author":"R Agrawal","year":"2017","unstructured":"Agrawal R, Gunasekeran DV, Grant R, Agarwal A, Kon OM, Nguyen QD, et al. Clinical Features and Outcomes of Patients With Tubercular Uveitis Treated With Antitubercular Therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017;135:1318\u201327.","journal-title":"JAMA Ophthalmol"},{"key":"3751_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0597-x","volume":"17","author":"R Agrawal","year":"2017","unstructured":"Agrawal R, Grant R, Gupta B, Gunasekeran DV, Gonzalez-Lopez JJ, Addison PKF, et al. What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis. BMC Ophthalmol. 2017;17:245.","journal-title":"BMC Ophthalmol"},{"key":"3751_CR25","doi-asserted-by":"publisher","first-page":"e000663","DOI":"10.1136\/bmjophth-2020-000663","volume":"6","author":"S Rahman","year":"2021","unstructured":"Rahman S, Irfan M, Siddiqui MAR. Role of interferon gamma release assay in the diagnosis and management of Mycobacterium tuberculosis-associated uveitis: a review. BMJ Open Ophthalmol. 2021;6:e000663.","journal-title":"BMJ Open Ophthalmol"},{"key":"3751_CR26","doi-asserted-by":"publisher","first-page":"e001225","DOI":"10.1136\/bmjresp-2022-001225","volume":"9","author":"OM Kon","year":"2022","unstructured":"Kon OM, Beare N, Connell D, Damato E, Gorsuch T, Hagan G, et al. BTS clinical statement for the diagnosis and management of ocular tuberculosis. BMJ Open Respir Res. 2022;9:e001225.","journal-title":"BMJ Open Respir Res"},{"key":"3751_CR27","volume":"14","author":"R Chawla","year":"2022","unstructured":"Chawla R, Singh MK, Singh L, Shah P, Kashyap S, Azad S, et al. Tubercular DNA PCR of ocular fluids and blood in cases of presumed ocular tuberculosis: a pilot study. Ther Adv Ophthalmol. 2022;14:25158414221123522.","journal-title":"Ther Adv Ophthalmol"},{"key":"3751_CR28","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1038\/s41433-024-03200-3","volume":"38","author":"I Putera","year":"2024","unstructured":"Putera I, Widodo E, Riasanti M, Waliyuddin MZ, Sitompul R, Edwar L, et al. Ocular tuberculosis with Mycobacterium tuberculosis DNA presence in ocular fluid: will post-COVID era bring a difference? Eye. 2024;38:3027\u20139.","journal-title":"Eye"},{"key":"3751_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/09273948.2017.1406529","volume":"27","author":"A Agarwal","year":"2019","unstructured":"Agarwal A, Agrawal R, Gunasekaran DV, Raje D, Gupta B, Aggarwal K, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 Report 3: Polymerase Chain Reaction in the Diagnosis and Management of Tubercular Uveitis: Global Trends. Ocul Immunol Inflamm. 2019;27:465\u201373.","journal-title":"Ocul Immunol Inflamm"},{"key":"3751_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10988","volume":"8","author":"I Putera","year":"2022","unstructured":"Putera I, La Distia Nora R, Utami N, Karuniawati A, Yasmon A, Wulandari D, et al. The impact of aqueous humor polymerase chain reaction and serological test results for establishing infectious uveitis diagnosis: An Indonesian experience. Heliyon. 2022;8:e10988.","journal-title":"Heliyon"},{"key":"3751_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0106-1","volume":"7","author":"X Qian","year":"2018","unstructured":"Qian X, Nguyen DT, Lyu J, Albers AE, Bi X, Graviss EA. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis. Emerg Microbes Infect. 2018;7:102.","journal-title":"Emerg Microbes Infect"},{"key":"3751_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.reuma.2017.09.008","volume":"15","author":"C Mill\u00e1n-Longo","year":"2019","unstructured":"Mill\u00e1n-Longo C, Peiteado D, Schlincker A, Hidalgo V, Pieren A, Balsa A, et al. Use of Immunomodulatory Drugs at a Uveitis Clinic. Reumatol Cl\u00edn. 2019;15:271\u20136.","journal-title":"Reumatol Cl\u00edn"},{"key":"3751_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2023;82:742\u201353.","journal-title":"Ann Rheum Dis"},{"key":"3751_CR34","doi-asserted-by":"publisher","first-page":"e241179","DOI":"10.1136\/bcr-2020-241179","volume":"14","author":"A Sachan","year":"2021","unstructured":"Sachan A, Chawla R, Lata S. Large exudative retinal detachment with choroidal granuloma unmasking disseminated tuberculosis: imaging and management. BMJ Case Rep. 2021;14:e241179.","journal-title":"BMJ Case Rep"},{"key":"3751_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03503-9","volume":"24","author":"J Zhu","year":"2024","unstructured":"Zhu J, Xu H, Chang Q, Chen F. Tuberculous ciliary body granuloma initially diagnosed as bullous retinal detachment: a case report. BMC Ophthalmol. 2024;24:236.","journal-title":"BMC Ophthalmol"},{"key":"3751_CR36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1080\/09273948.2018.1485958","volume":"27","author":"JH Song","year":"2019","unstructured":"Song JH, Koreishi AF, Goldstein DA. Tuberculous Uveitis Presenting with a Bullous Exudative Retinal Detachment: A Case Report and Systematic Literature Review. Ocul Immunol Inflamm. 2019;27:998\u20131009.","journal-title":"Ocul Immunol Inflamm"},{"key":"3751_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12348-012-0079-5","volume":"2","author":"EJ Davis","year":"2012","unstructured":"Davis EJ, Rathinam SR, Okada AA, Tow SL, Petrushkin H, Graham EM, et al. Clinical spectrum of tuberculous optic neuropathy. J Ophthalmic Inflamm Infect. 2012;2:183\u20139.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"3751_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/tropicalmed6030148","volume":"6","author":"KM Laycock","year":"2021","unstructured":"Laycock KM, Enane LA, Steenhoff AP. Tuberculosis in Adolescents and Young Adults: Emerging Data on TB Transmission and Prevention among Vulnerable Young People. Trop Med Infect Dis. 2021;6:148.","journal-title":"Trop Med Infect Dis"},{"key":"3751_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S2352-4642(19)30337-2","volume":"4","author":"KJ Snow","year":"2020","unstructured":"Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, et al. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020;4:68\u201379.","journal-title":"Lancet Child Adolesc Health"},{"key":"3751_CR40","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.3390\/jcm10245888","volume":"10","author":"P Caraux-Paz","year":"2021","unstructured":"Caraux-Paz P, Diamantis S, de Wazi\u00e8res B, Gallien S. Tuberculosis in the Elderly. J Clin Med. 2021;10:5888.","journal-title":"J Clin Med"},{"key":"3751_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/microorganisms12040775","volume":"12","author":"E Quiros-Roldan","year":"2024","unstructured":"Quiros-Roldan E, Sottini A, Natali PG, Imberti L. The Impact of Immune System Aging on Infectious Diseases. Microorganisms. 2024;12:775.","journal-title":"Microorganisms"},{"key":"3751_CR42","doi-asserted-by":"crossref","unstructured":"Putera I, Ten Berge J, Thiadens A, Dik WA, Agrawal R, van Hagen PM et al. Clinical Features and Predictors of Treatment Outcome in Patients with Ocular Tuberculosis from the Netherlands and Indonesia: The OculaR TB in Low versus High Endemic Countries (ORTEC) Study. Ocul Immunol Inflamm 2024: 1-12.","DOI":"10.1080\/09273948.2024.2359614"},{"key":"3751_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1869-5760-3-25","volume":"3","author":"K Sharma","year":"2013","unstructured":"Sharma K, Gupta V, Bansal R, Sharma A, Sharma M, Gupta A. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect. 2013;3:25.","journal-title":"J Ophthalmic Inflamm Infect"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03751-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03751-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03751-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:23:55Z","timestamp":1748867035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03751-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3751"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03751-z","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}